
NORML Launches 2026 Cannabis Freedom Survey Ahead of 4/20
National advocacy group seeks data on consumer access and restrictions across legal markets
The National Organization for the Reform of Marijuana Laws is polling cannabis consumers nationwide about their access to legal marijuana ahead of the April 20 holiday, launching what it's calling the 2026 Cannabis Freedom Survey.
The initiative comes as the reform landscape has shifted dramatically over the past two years. Twenty-four states now allow adult-use sales, while another 14 permit medical marijuana only. But the patchwork of regulations means consumer experiences vary wildly depending on zip code.
NORML's survey asks respondents to evaluate their local cannabis freedoms, from purchasing options to cultivation rights to consumption venues. The organization plans to compile the data into a comprehensive report on how legalization is working—or not working—for everyday users.
Why This Matters Now
The timing reflects growing concerns among advocates about the gap between legalization on paper and practical access. Several states with legal frameworks still lack retail infrastructure. Others impose taxes exceeding 30% or restrict home cultivation entirely.
"We're seven years into adult-use legalization in many states, and the question isn't just whether cannabis is legal anymore," said Paul Armentano, NORML's deputy director. "It's whether people can actually access it affordably and safely."
The survey arrives as federal rescheduling discussions continue. The DEA's proposed move of marijuana from Schedule I to Schedule III would maintain federal prohibition while acknowledging medical value—a half-measure that frustrates many in the reform community.
The Regional Divide
Early responses to the survey highlight stark regional differences. West Coast consumers report broad access to diverse products and competitive pricing. Meanwhile, newer markets in the Northeast face supply constraints and limited retail locations.
Medical-only states present their own challenges. Qualifying conditions vary dramatically. Florida's medical program serves over 800,000 patients. In contrast, states like Louisiana have fewer than 10,000 registered users despite similar population sizes.
Home cultivation represents another flashpoint. While states like Michigan and Maine allow adults to grow up to 12 plants, Washington and New Jersey prohibit home grows entirely. The survey specifically probes cultivation access as a measure of true cannabis freedom.
What Advocates Want
NORML plans to release survey findings before summer, potentially influencing state legislative sessions still in progress. The organization has identified several priority areas based on preliminary responses.
Expungement remains incomplete in most legal states. Estimates suggest only 10-15% of eligible convictions have been cleared, despite automatic expungement provisions in some state laws. Administrative backlogs and bureaucratic hurdles slow the process.
Social consumption venues represent another gap. Nevada and Alaska allow licensed lounges, but most states restrict use to private residences. This effectively prohibits consumption for renters whose landlords forbid it, tourists, and anyone without private space.
The 4/20 Connection
The survey's release ahead of April 20 is strategic. The date has evolved from counterculture celebration to major industry sales event. Dispensaries reported record single-day revenues last year, with some locations seeing 200-300% increases over normal Saturday traffic.
But the holiday also highlights ongoing criminalization. An estimated 350,000 people were arrested for marijuana possession in 2024, according to FBI data—down from peak levels but still representing one arrest every 90 seconds.
For NORML, the survey serves dual purposes: gathering hard data on consumer experiences while raising awareness about remaining restrictions. The organization has used similar polling in the past to identify problem areas and target advocacy efforts.
What Comes Next
Participants can access the survey through NORML's website through May 1. The organization expects several thousand responses based on previous polling efforts.
Results will be broken down by state and market type—adult-use versus medical-only versus prohibition states. NORML plans to share findings with state legislators, regulators, and industry stakeholders.
The broader question is whether the data will influence policy. Several states are considering legalization measures for 2026 ballots, including Idaho and Nebraska. Survey results could provide ammunition for reform campaigns or, conversely, highlight implementation challenges that opponents might exploit.
For now, advocates are focused on documentation. As Armentano put it: "You can't fix what you don't measure."
This article is based on original reporting by www.marijuanamoment.net.
Original Source
This article is based on reporting from Marijuana Moment.
Read the original articleOriginal title: "Marijuana Reform Group Polls Consumers About Freedoms Where They Live Ahead Of 4/20"
Related Topics
Related Stories
LegislationNebraska Senator Challenges State's Proposed Hemp Restrictions
A Nebraska senator is challenging proposed hemp regulations from state agriculture officials, accusing them of trying to ban legal products and threatening a $10 million industry employing 2,000 workers.
LegislationTexas Judge Blocks Hemp Rules, Restores THCA Flower Sales
A Travis County judge temporarily blocked Texas from enforcing hemp rules that removed THCA flower from shelves, giving the state's hemp industry a short-term reprieve in an ongoing regulatory battle.
LegislationNORML Survey Reveals Wide Gap Between Cannabis Legalization and User Freedom
NORML's new survey reveals significant gaps between cannabis legalization laws and actual consumer freedom, with experiences varying widely across legal markets.
More from David Okonkwo
View all articles
NORML Survey Reveals Wide Gap Between Cannabis Legalization and User Freedom

Cleveland Council Eyes Cannabis Tax Revenue for Local Projects

Florida Medicaid Settlement Funds Traced to Anti-Legalization Campaign

